Flora Growth (FLGC)
(Delayed Data from NSDQ)
$1.52 USD
+0.02 (1.33%)
Updated May 8, 2024 04:00 PM ET
After-Market: $1.50 -0.02 (-1.32%) 6:42 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
Flora Growth Corp. [FLGC]
Reports for Purchase
Showing records 1 - 20 ( 44 total )
Company: Flora Growth Corp.
Industry: Medical - Products
Company: Flora Growth Corp.
Industry: Medical - Products
Company: Flora Growth Corp.
Industry: Medical - Products
Cannabis Industry Update: November 2023 Performance Valuations
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Flora Growth Corp.
Industry: Medical - Products
Cannabis Industry Update: August 2023 Perfromance and Valuations
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Flora Growth Corp.
Industry: Medical - Products
Company: Flora Growth Corp.
Industry: Medical - Products
Problems in Colombia - U.S. Bright Spot
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Flora Growth Corp.
Industry: Medical - Products
Company: Flora Growth Corp.
Industry: Medical - Products
Cannabis Industry Update: 1Q23 Cannabis Performance, Sales, and Valuation
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Flora Growth Corp.
Industry: Medical - Products
Company: Flora Growth Corp.
Industry: Medical - Products
Company: Flora Growth Corp.
Industry: Medical - Products
Company: Flora Growth Corp.
Industry: Medical - Products
Updating 3Q22 After Raise and LT Outlook Toward Profitability, PT to $1
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Flora Growth Corp.
Industry: Medical - Products
Company: Flora Growth Corp.
Industry: Medical - Products
Acquiring German Distribution to Leverage Colombian THC, Lower PT to $2
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Flora Growth Corp.
Industry: Medical - Products
Company: Flora Growth Corp.
Industry: Medical - Products
1H22 Light with Several Moving Parts, Prioritizing High Margin Mix, PT $3
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Flora Growth Corp.
Industry: Medical - Products
Cannabis Industry Update: 2Q22 Week II Earnings Preview
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Flora Growth Corp.
Industry: Medical - Products
Weekly ReHash: Alternative Financing Solutions Remains In High Demand
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Flora Growth Corp.
Industry: Medical - Products
Company: Flora Growth Corp.
Industry: Medical - Products
New CFO Brings E-Commerce Expertise, & Colombia Moves Toward Legalization
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S